Dierk H. Endemann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dierk H. Endemann has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Christian Schach
Department of Cardiology, University Medical Center Regensburg, 93053 Regensburg, Germany
2 shared publications Günter A. J. Riegger
University Hospital Regensburg
2 shared publications- Abdellatif Bouazzaoui
Department of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, P.O. Box 715, Makkah 21955, Saudi Arabia
1 shared publication Alois Philipp
University Hospital Regensburg
1 shared publicationAndreas Luchner
University Hospital Regensburg
1 shared publication- Andreas Luchner
Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany
1 shared publication
Latest Publications
- 1 January 2017
- Published by SAGE Publications in Cell Transplantation
Acute renal graft-versus-host disease in a murine model of allogeneic bone marrow transplantation
Acute kidney injury (AKI) is a very common complication after allogeneic bone marrow transplantation (BMT) and associated with poor prognosis. Generally kidneys are assumed to be no direct target of Graft-versus-Host Disease (GvHD), and renal impairment is often attributed to several other factors occurring in the early phase after BMT. Our study aimed to prove the existence of renal GvHD in a fully MHC-mismatched model of BALB/c mice conditioned and transplanted according to two different intensity protocols. Syngeneically transplanted and untreated animals served as controls. 4 weeks after transplantation, allogeneic animals developed acute GvHD that was more pronounced in the high-intensity protocol (HIP) group than in the low-intensity protocol (LIP) group. Urea and creatinine as classic serum markers of renal function could not verify renal impairment 4 weeks after BMT. Creatinine levels were even reduced as a result of catabolic metabolism and loss of muscle mass due to acute GvHD. Proteinuria, albuminuria, and urinary N-acetyl-beta-Dglucosaminidase (NAG) levels were measured as additional renal markers before and after transplantation. Albuminuria and NAG were only significantly increased after allogeneic transplantation, correlating with disease severity between HIP and LIP animals. Histological investigations of the kidneys showed renal infiltration of T-cells and macrophages with endarteriitis, interstitial nephritis, tubulitis, and glomerulitis. T-cells consisted of CD4+, CD8+, and FoxP3+ cells. Renal expression analysis of allogeneic animals showed increases in indoleamine-2,3 dioxygenase (IDO), different cytokines (TNFα, IFN-γ, IL-1α, IL2, IL-6, and IL-10), and adhesion molecules (ICAM-1 and VCAM-1), resembling findings from other tissues in acute GvHD. In summary, our study supports the entity of renal GvHD with histological features suggestive of cell-mediated renal injury. Albuminuria and urinary NAG levels may serve as early markers of renal impairment.
- 1 January 2017
- Published by SAGE Publications in Cell Transplantation
Acute renal graft-versus-host disease in a murine model of allogeneic bone marrow transplantation
Acute kidney injury (AKI) is a very common complication after allogeneic bone marrow transplantation (BMT) and associated with poor prognosis. Generally kidneys are assumed to be no direct target of Graft-versus-Host Disease (GvHD), and renal impairment is often attributed to several other factors occurring in the early phase after BMT. Our study aimed to prove the existence of renal GvHD in a fully MHC-mismatched model of BALB/c mice conditioned and transplanted according to two different intensity protocols. Syngeneically transplanted and untreated animals served as controls. 4 weeks after transplantation, allogeneic animals developed acute GvHD that was more pronounced in the high-intensity protocol (HIP) group than in the low-intensity protocol (LIP) group. Urea and creatinine as classic serum markers of renal function could not verify renal impairment 4 weeks after BMT. Creatinine levels were even reduced as a result of catabolic metabolism and loss of muscle mass due to acute GvHD. Proteinuria, albuminuria, and urinary N-acetyl-beta-Dglucosaminidase (NAG) levels were measured as additional renal markers before and after transplantation. Albuminuria and NAG were only significantly increased after allogeneic transplantation, correlating with disease severity between HIP and LIP animals. Histological investigations of the kidneys showed renal infiltration of T-cells and macrophages with endarteriitis, interstitial nephritis, tubulitis, and glomerulitis. T-cells consisted of CD4+, CD8+, and FoxP3+ cells. Renal expression analysis of allogeneic animals showed increases in indoleamine-2,3 dioxygenase (IDO), different cytokines (TNFα, IFN-γ, IL-1α, IL2, IL-6, and IL-10), and adhesion molecules (ICAM-1 and VCAM-1), resembling findings from other tissues in acute GvHD. In summary, our study supports the entity of renal GvHD with histological features suggestive of cell-mediated renal injury. Albuminuria and urinary NAG levels may serve as early markers of renal impairment.
- 13 October 2011
- Published by Springer Nature in Intensive Care Medicine
- Vol. 37 (12) , 2046-2049
A simple method of vascular access to perform emergency coronary angiography in patients with veno-arterial extracorporeal membrane oxygenation
- 13 October 2011
- Published by Springer Nature in Intensive Care Medicine
- Vol. 37 (12) , 2046-2049
A simple method of vascular access to perform emergency coronary angiography in patients with veno-arterial extracorporeal membrane oxygenation
- Open Access
- 1 January 2011
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 10 (1) , 94
Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report
Aldosterone levels are elevated in a rat model of type 2 diabetes mellitus, the Zucker Diabetic fatty rat (ZDF). Moreover blood pressure in ZDF rats is salt-sensitive. The aim of this study was to examine the effect of the aldosterone antagonist eplerenone on structural and mechanical properties of resistance arteries of ZDF-rats on normal and high-salt diet. After the development of diabetes, ZDF animals were fed either a normal salt diet (0.28%) or a high-salt diet (5.5%) starting at an age of 15 weeks. ZDF rats on high-salt diet were randomly assigned to eplerenone (100 mg/kg per day, in food) (ZDF+S+E), hydralazine (25 mg/kg per day) (ZDF+S+H), or no treatment (ZDF+S). Rats on normal salt-diet were assigned to eplerenone (ZDF+E) or no treatment (ZDF). Normoglycemic Zucker lean rats were also divided into two groups receiving normal (ZL) or high-salt diet (ZL+S) serving as controls. Systolic blood pressure was measured by tail cuff method. The experiment was terminated at an age of 25 weeks. Mesenteric resistance arteries were studied on a pressurized myograph. Specifically, vascular hypertrophy (media-to-lumen ratio) and vascular stiffness (strain and stress) were analyzed. After pressurized fixation histological analysis of collagen and elastin content was performed. Blood pressure was significantly higher in salt-loaded ZDF compared to ZDF. Eplerenone and hydralazine prevented this rise similarily, however, significance niveau was missed. Media-to-lumen ratio of mesenteric resistance arteries was significantly increased in ZDF+S when compared to ZDF and ZL. Both, eplerenone and hydralazine prevented salt-induced vascular hypertrophy. The strain curve of arteries of salt-loaded ZDF rats was significantly lower when compared to ZL and when compared to ZDF+S+E, but was not different compared to ZDF+S+H. Eplerenone, but not hydralazine shifted the strain-stress curve to the right indicating a vascular wall composition with less resistant components. This indicates increased vascular stiffness in salt-loaded ZDF rats, which could be prevented by eplerenone but not by hydralazine. Collagen content was increased in ZL and ZDF rats on high-salt diet. Eplerenone and hydralazine prevented the increase of collagen content. There was no difference in elastin content. Eplerenone and hydralazine prevented increased media-to-lumen ratio in salt-loaded ZDF-rats, indicating a regression of vascular hypertrophy, which is likely mediated by the blood pressure lowering-effect. Eplerenone has additionally the potential to prevent increased vascular stiffness in salt-loaded ZDF-rats. This suggests an effect of the specific aldosterone antagonist on adverse vascular wall remodelling.
- 1 January 2011
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 10 (1) , 94
Open AccessEplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report
Aldosterone levels are elevated in a rat model of type 2 diabetes mellitus, the Zucker Diabetic fatty rat (ZDF). Moreover blood pressure in ZDF rats is salt-sensitive. The aim of this study was to examine the effect of the aldosterone antagonist eplerenone on structural and mechanical properties of resistance arteries of ZDF-rats on normal and high-salt diet. After the development of diabetes, ZDF animals were fed either a normal salt diet (0.28%) or a high-salt diet (5.5%) starting at an age of 15 weeks. ZDF rats on high-salt diet were randomly assigned to eplerenone (100 mg/kg per day, in food) (ZDF+S+E), hydralazine (25 mg/kg per day) (ZDF+S+H), or no treatment (ZDF+S). Rats on normal salt-diet were assigned to eplerenone (ZDF+E) or no treatment (ZDF). Normoglycemic Zucker lean rats were also divided into two groups receiving normal (ZL) or high-salt diet (ZL+S) serving as controls. Systolic blood pressure was measured by tail cuff method. The experiment was terminated at an age of 25 weeks. Mesenteric resistance arteries were studied on a pressurized myograph. Specifically, vascular hypertrophy (media-to-lumen ratio) and vascular stiffness (strain and stress) were analyzed. After pressurized fixation histological analysis of collagen and elastin content was performed. Blood pressure was significantly higher in salt-loaded ZDF compared to ZDF. Eplerenone and hydralazine prevented this rise similarily, however, significance niveau was missed. Media-to-lumen ratio of mesenteric resistance arteries was significantly increased in ZDF+S when compared to ZDF and ZL. Both, eplerenone and hydralazine prevented salt-induced vascular hypertrophy. The strain curve of arteries of salt-loaded ZDF rats was significantly lower when compared to ZL and when compared to ZDF+S+E, but was not different compared to ZDF+S+H. Eplerenone, but not hydralazine shifted the strain-stress curve to the right indicating a vascular wall composition with less resistant components. This indicates increased vascular stiffness in salt-loaded ZDF rats, which could be prevented by eplerenone but not by hydralazine. Collagen content was increased in ZL and ZDF rats on high-salt diet. Eplerenone and hydralazine prevented the increase of collagen content. There was no difference in elastin content. Eplerenone and hydralazine prevented increased media-to-lumen ratio in salt-loaded ZDF-rats, indicating a regression of vascular hypertrophy, which is likely mediated by the blood pressure lowering-effect. Eplerenone has additionally the potential to prevent increased vascular stiffness in salt-loaded ZDF-rats. This suggests an effect of the specific aldosterone antagonist on adverse vascular wall remodelling.
- 1 September 2002
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 52 (09) , 677-683
Volume Independent Stimulation of Renin Secretion by a Single Dose of Amiloride in Man
The regulation of renin secretion is not understood in detail. There is evidence that amiloride (CAS 17440-83-4) has a stimulatory effect on the renin secretion but it is still in question whether this is volume and/or sodium independent. The purpose of this study was to investigate whether a single dose of amiloride has a direct stimulatory effect on the renin secretion in humans independent of its diuretic effect. Blood pressure, plasma renin activities and plasma aldosterone concentrations as well as serum electrolytes and serum creatinine were assessed in 11 healthy male humans over a period of 6 hours after a single dose of 20 mg of amiloride (Midamor ®), or placebo. Furthermore every hour urine was collected for analysis of urinary creatinine and electrolytes. To avoid a possible effect on the renin secretion via augmented diuresis induced by amiloride the urinary volume loss was replaced by 0.9 % NaCl solution. There was a decrease in plasma renin activities and plasma aldosterone concentrations after amiloride and placebo administration, but the plasma renin activity after amiloride was significantly higher compared with placebo. Also the plasma aldosterone concentration was higher after amiloride compared with placebo, but the difference did not reach statistical significance. Serum and urinary concentrations of sodium and potassium clearly confirmed the known potassium-saving and natriuretic effect of amiloride. Serum creatinine concentrations decreased and urinary sodium chloride concentrations increased due to the administered volume load using physiologic sodium chloride solution. The present study provides evidence that amiloride induces renin secretion by direct mechanisms in man, which might go along with augmented aldosterone secretion. Volumenunabhängige Stimulation der Renin-Sekretion durch eine einmalige Gabe von Amilorid beim Menschen Die Regulation der Reninsekretion ist nicht in allen Details aufgeklärt. Es gibt Hinweise darauf, daß Amilorid (CAS 17440-83-4) die Renin-Sekretion stimuliert, jedoch ist unklar, ob dieser Effekt unabhängig von der diuretischen Wirkung von Amilorid ist. Das Ziel der vorliegenden Studie war zu untersuchen, ob eine einmalige Gabe von Amilorid die Sekretion von Renin beim Menschen direkt (unabhängig von einem diuretischen Effekt) stimuliert. Blutdruck, Plasma-Renin-Aktivität und Plasma-Aldosteron-Konzentration sowie Serum-Elektrolyte und Serum-Kreatinin wurden bei 11 gesunden Männern über eine Dauer von 6 Stunden nach einer einmaligen Gabe von 20 mg Amilorid (Midamor ®) oder Plazebo gemessen. Ferner wurde jede Stunde Urin zur Bestimmung von Kreatinin und Elektrolyten gesammelt. Um einen möglichen Einfluß einer durch Amilorid vermehrten Diurese auf die Renin-Sekretion zu vermeiden, wurde der Volumenverlust im Urin durch 0,9%iger Natriumchlorid-Lösung ersetzt. Sowohl nach Gabe von Amilorid als auch Plazebo war ein Rückgang der Plasma-Renin-Aktivität und Plasma-Aldosteron-Konzentration zu verzeichnen, jedoch war die Plasma-Renin-Aktivität nach Amilorid-Gabe signifikant höher als nach Gabe von Plazebo. Die Plasma-Aldosteron-Konzentration war nach Amilorid ebenfalls höher als nach Plazebo, dieser Unterschied erreichte jedoch kein Signifikanzniveau. Serum- und Urinkonzentrationen von Natrium und Kalium zeigten deutlich den bekannten kaliumsparenden und natriuretischen Effekt von Amilorid. Mittels Infusionen von physiologischer Natriumchlorid-Lösung sanken die Serum-Kreatinin-Konzentrationen, und im Urin stiegen die Natriumchlorid-Konzentrationen an. Die Ergebnisse der vorliegenden Studie sprechen für einen direkten stimulierenden Effekt von Amilorid auf die Renin-Sekretion beim Menschen mit möglicherweise konsekutiv vermehrter Aldosteron-Sekretion.
- 1 September 2002
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 52 (09) , 677-683
Volume Independent Stimulation of Renin Secretion by a Single Dose of Amiloride in Man
The regulation of renin secretion is not understood in detail. There is evidence that amiloride (CAS 17440-83-4) has a stimulatory effect on the renin secretion but it is still in question whether this is volume and/or sodium independent. The purpose of this study was to investigate whether a single dose of amiloride has a direct stimulatory effect on the renin secretion in humans independent of its diuretic effect. Blood pressure, plasma renin activities and plasma aldosterone concentrations as well as serum electrolytes and serum creatinine were assessed in 11 healthy male humans over a period of 6 hours after a single dose of 20 mg of amiloride (Midamor ®), or placebo. Furthermore every hour urine was collected for analysis of urinary creatinine and electrolytes. To avoid a possible effect on the renin secretion via augmented diuresis induced by amiloride the urinary volume loss was replaced by 0.9 % NaCl solution. There was a decrease in plasma renin activities and plasma aldosterone concentrations after amiloride and placebo administration, but the plasma renin activity after amiloride was significantly higher compared with placebo. Also the plasma aldosterone concentration was higher after amiloride compared with placebo, but the difference did not reach statistical significance. Serum and urinary concentrations of sodium and potassium clearly confirmed the known potassium-saving and natriuretic effect of amiloride. Serum creatinine concentrations decreased and urinary sodium chloride concentrations increased due to the administered volume load using physiologic sodium chloride solution. The present study provides evidence that amiloride induces renin secretion by direct mechanisms in man, which might go along with augmented aldosterone secretion. Volumenunabhängige Stimulation der Renin-Sekretion durch eine einmalige Gabe von Amilorid beim Menschen Die Regulation der Reninsekretion ist nicht in allen Details aufgeklärt. Es gibt Hinweise darauf, daß Amilorid (CAS 17440-83-4) die Renin-Sekretion stimuliert, jedoch ist unklar, ob dieser Effekt unabhängig von der diuretischen Wirkung von Amilorid ist. Das Ziel der vorliegenden Studie war zu untersuchen, ob eine einmalige Gabe von Amilorid die Sekretion von Renin beim Menschen direkt (unabhängig von einem diuretischen Effekt) stimuliert. Blutdruck, Plasma-Renin-Aktivität und Plasma-Aldosteron-Konzentration sowie Serum-Elektrolyte und Serum-Kreatinin wurden bei 11 gesunden Männern über eine Dauer von 6 Stunden nach einer einmaligen Gabe von 20 mg Amilorid (Midamor ®) oder Plazebo gemessen. Ferner wurde jede Stunde Urin zur Bestimmung von Kreatinin und Elektrolyten gesammelt. Um einen möglichen Einfluß einer durch Amilorid vermehrten Diurese auf die Renin-Sekretion zu vermeiden, wurde der Volumenverlust im Urin durch 0,9%iger Natriumchlorid-Lösung ersetzt. Sowohl nach Gabe von Amilorid als auch Plazebo war ein Rückgang der Plasma-Renin-Aktivität und Plasma-Aldosteron-Konzentration zu verzeichnen, jedoch war die Plasma-Renin-Aktivität nach Amilorid-Gabe signifikant höher als nach Gabe von Plazebo. Die Plasma-Aldosteron-Konzentration war nach Amilorid ebenfalls höher als nach Plazebo, dieser Unterschied erreichte jedoch kein Signifikanzniveau. Serum- und Urinkonzentrationen von Natrium und Kalium zeigten deutlich den bekannten kaliumsparenden und natriuretischen Effekt von Amilorid. Mittels Infusionen von physiologischer Natriumchlorid-Lösung sanken die Serum-Kreatinin-Konzentrationen, und im Urin stiegen die Natriumchlorid-Konzentrationen an. Die Ergebnisse der vorliegenden Studie sprechen für einen direkten stimulierenden Effekt von Amilorid auf die Renin-Sekretion beim Menschen mit möglicherweise konsekutiv vermehrter Aldosteron-Sekretion.